CannCure Investments Inc. entered into a letter of intent to acquire Goldstream Minerals Inc. (TSXV:GSX.H) in a reverse merger transaction on January 8, 2020. CannCure Investments Inc. entered into a definitive agreement to acquire Goldstream Minerals Inc. (TSXV:GSX.H) in a reverse merger transaction on February 20, 2020. Pursuant to the transaction, the issued and outstanding common shares of Goldstream Minerals Inc. will be consolidated such that the exchange ratio of the transaction will be 1:1. Goldstream's common shares will be consolidated on a 23.3053:1 basis. As of March 19, 2020, it was announced that Goldstream will consolidate all of its issued and outstanding common shares on a revised ratio of 16.07201 old common shares for 1 new common share. As of May 11, 2020, Goldstream Minerals Inc. has completed the consolidation of all of its issued and outstanding common shares on the basis of 16.07201 pre-Consolidation common shares for each 1 post consolidation common share (16.07201:1). SOL Global Investments Corp., the parent of CannCure Investments Inc., will transfer a portion of its common shareholding in CannCure Investments Inc. to the former shareholders of CannCure Investments Inc. in accordance with the terms of the amended and restated purchase agreement dated April 8, 2019 between SOL Global Investments Corp. and the former shareholders of CannCure Investments Inc. Certain shareholders of CannCure Investments Inc. shall be subject to lock-up provisions. SOL Global Investments Corp. will remain the largest shareholder of the resulting issuer. The entity resulting from the transaction would continue to carry on the business of CannCure Investments Inc. as a multi-state vertically integrated Cannabis Company to be called “Bluma Wellness Inc.” with operations in Florida and California. The resulting issuer's shares will become listed on the Canadian Stock Exchange. As of May 8, 2020, Goldstream Minerals has amended its articles in accordance with the Canada Business Corporations Act and changed its name to "Bluma Wellness Inc.”

The board of directors and management of the resulting issuer will be comprised of the following individuals: Brady Cobb, Chief Executive Officer and Director, Michael Bondurant, President and Chief Strategy Officer, Michael Smuts, Chief Operating Officer, Chris Polaszek, Chief Legal Officer and Corporate Secretary, Cody Stross, Chief Cultivation Officer and Director, Chad Moss, Chairman of the Board of Directors and Adam Wilks, Director. As of March 19, 2020, it was announced that Harry Rosenfeld will become the Chief Financial Officer of the resulting issuer. Michael Bondurant will now stand for election to become a director of the resulting issuer together with Brady Cobb, Chad Moss and Adam Wilks at Goldstream's annual and special meeting of shareholders on April 9, 2020. If successfully elected, then upon the closing of the transaction, Brady Cobb, Chad Moss, Adam Wilks and Michael Bondurant will comprise the Board of Directors of the resulting issuer and the incumbent directors of Goldstream will resign. Additionally, Cody Stross will no longer stand for election to become a director of the resulting issuer upon completion of the transaction and instead will be appointed to the board only if the proposed acquisition of Northern Emeralds is successfully completed. The Board of Directors and management of the resulting issuer will be replaced with nominees of CannCure Investments Inc. Brady Cobb will transition from Chief Executive Officer of SOL Global Investments Corp., the parent of CannCure Investments Inc., to lead the resulting issuer as Chief Executive Officer and Chairman. As of April 15, 2020, Goldstream announced that its shareholder approved, on a meeting held on April 9, 2020, fixing the number of the directors at four following the completion of the transaction, election of new directors upon completion of the transaction and name change of the company.

The transaction is subject to approvals of shareholders of CannCure and Goldstream Minerals. The transaction is also subject to CSE approval, third party approvals, lock-up agreement, listing of new shares in stock exchange, obtaining financing, delisting of company stock, resignation of directors of Goldstream Minerals, consummation of private placement, board approval of Goldstream Minerals and reverse stock split of shares upon completion of the transaction. On May 22, 2020, CannCure shareholders held a special meeting where they approved the amalgamation of CannCure. Computershare Trust Company of Canada acted as registrar and Steven Agnew of Irwin Lowy LLP acted as legal advisor to Goldstream Minerals. Peter Simeon of Gowling WLG (Canada) LLP acted as legal advisor to CannCure Investments.

CannCure Investments Inc. completed the acquisition of Goldstream Minerals Inc. (TSXV:GSX.H) in a reverse merger transaction on June 11, 2020. As a result of the amalgamation, all CannCure common shares were exchanged for shares of Goldstream on a 1:1 basis; and all outstanding warrants and convertible debentures to purchase CannCure Shares were exchanged on an equivalent basis for warrants and convertible debentures to purchase shares of Goldstream. SOL Global Investments Corp. received an aggregate of 16.07 million shares and 6.45 million warrants and now holds 19.41% of the issued and outstanding shares of the resulting issuer on a non-diluted basis and 19.99% on a partially diluted basis.. Upon completion, shareholders of CannCure Investments now hold approximately 98.18% stake in resulting issuer and pre-transaction shareholders of Goldstream Minerals now hold 1.82%, in each case, on a non-diluted basis, based on an aggregate of 82.8 million shares of resulting issuer, currently issued and outstanding. The common shares of the resulting issuer will commence trading on the Canadian Securities Exchange under the symbol "BWEL" once the CSE's conditions for listing are satisfied and the CSE issues its final exchange bulletin confirming the completion of the transaction.